KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) EBITDA Margin: 2018-2025

Historic EBITDA Margin for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -27.17%.

  • Twist Bioscience's EBITDA Margin rose 1349.00% to -27.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -20.65%, marking a year-over-year increase of 4597.00%. This contributed to the annual value of -20.65% for FY2025, which is 4596.00% up from last year.
  • Per Twist Bioscience's latest filing, its EBITDA Margin stood at -27.17% for Q3 2025, which was down 229.28% from 21.02% recorded in Q2 2025.
  • Over the past 5 years, Twist Bioscience's EBITDA Margin peaked at 21.02% during Q2 2025, and registered a low of -127.80% during Q1 2022.
  • In the last 3 years, Twist Bioscience's EBITDA Margin had a median value of -59.89% in 2023 and averaged -55.28%.
  • In the last 5 years, Twist Bioscience's EBITDA Margin tumbled by 3,323bps in 2021 and then spiked by 12,615bps in 2025.
  • Quarterly analysis of 5 years shows Twist Bioscience's EBITDA Margin stood at -108.00% in 2021, then skyrocketed by 2,862bps to -79.38% in 2022, then soared by 1,949bps to -59.89% in 2023, then spiked by 2,413bps to -35.76% in 2024, then soared by 1,349bps to -27.17% in 2025.
  • Its EBITDA Margin stands at -27.17% for Q3 2025, versus 21.02% for Q2 2025 and -42.38% for Q1 2025.